14-day Premium Trial Subscription Try For FreeTry Free

Adma Biologics (ADMA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

02:00pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Adma Biologics (ADMA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Editas Medicine (EDIT) Reports Q2 Loss, Tops Revenue Estimates

11:55am, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Editas (EDIT) delivered earnings and revenue surprises of 7.14% and 19.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Conference Call Scheduled for August 10, 2022, at 4:30 p.m. ET Conference Call Scheduled for August 10, 2022, at 4:30 p.m. ET
Conference Call Scheduled for August 10, 2022, at 4:30 p.m. ET Conference Call Scheduled for August 10, 2022, at 4:30 p.m. ET

Seattle Genetics (SGEN) Reports Q2 Loss, Tops Revenue Estimates

09:15pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Seattle Genetics (SGEN) delivered earnings and revenue surprises of 10.98% and 12.26%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Need to Knows for Trading Penny Stocks in July 

03:30pm, Sunday, 17'th Jul 2022 PennyStocks
Which penny stocks are you buying right now? The post Need to Knows for Trading Penny Stocks in July  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Need to Knows for Trading Penny Stocks in July

11:30am, Sunday, 17'th Jul 2022
Which penny stocks are you buying right now? The post Need to Knows for Trading Penny Stocks in July  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

ADMA Biologics: A Path To Profits Looks Clear

02:12pm, Thursday, 12'th May 2022
ADMA reported a great quarter in all respects. Management gave great guidance for 2024-2025 which shows that ADMA is undervalued with an enterprise value of only $324M.

Adma Biologics (ADMA) Reports Q1 Loss, Tops Revenue Estimates

09:45pm, Wednesday, 11'th May 2022 Zacks Investment Research
Adma Biologics (ADMA) delivered earnings and revenue surprises of -25% and 9.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Adma Biologics (ADMA) delivered earnings and revenue surprises of -25% and 9.82%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ADMA Biologics, Inc. (NASDAQ:ADMA ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Skyler Bloom - Senior Director, Business Development and Corporate Strategy Adam Gross

Moderna (MRNA) Q1 Earnings and Revenues Top Estimates

12:25pm, Wednesday, 04'th May 2022 Zacks Investment Research
Moderna (MRNA) delivered earnings and revenue surprises of 65.64% and 34.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Conference Call Scheduled for May 11, 2022 at 4:30 p.m. ET Conference Call Scheduled for May 11, 2022 at 4:30 p.m. ET

ADMA: Pertinent Updates

12:46pm, Monday, 18'th Apr 2022
Institutional ownership has grown in the past 6 months. An activist investor is watching ADMA intently.
Can these penny stocks continue to climb after a bearish trading day? The post Best Penny Stocks to Watch After the Stock Market Takes a Bear Turn appeared first on Penny Stocks to Buy, Picks, News an
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE